Skip to main content
. 2014 Apr 24;4:743–756. doi: 10.1016/j.nicl.2014.04.011

Fig. 1.

Fig. 1

Gadolinium (Gd)-enhancing lesions are present in the brainstem, cerebellum and periventricular area of EAE mice. (A) through (C) show images for naive mice following administration of Gd, where no enhancement is seen. (D) through (F) show images for EAE mice where Gd enhancement is seen with T1-weighted imaging in the brainstem, cerebellum and periventricular area (white arrows).

(Adapted from Smorodchenko et al. (2007).)